Acute Promyelocytic Leukemia
specificAcute promyelocytic leukemia (APL) is a distinct subtype of acute myeloid leukemia (AML), and it is treated differently than other types of AML because of its marked sensitivity to differentiating effects of all trans-retinoic acid. APL is characterized by a severe coagulopathy which may be present at diagnosis. APL occurs in 7 % of children with AML.
29
Centers
14
Active Trials
$10M
Cancer Funding
Top Centers for Acute Promyelocytic Leukemia(29)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive High-Volume Research Center | 80.3 |
| 2 | The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive High-Volume Research Center | 77.8 |
| 3 | Siteman Cancer CenterSt. Louis, MO NCI Comprehensive High-Volume Research Center | 74.2 |
| 4 | UCSF Helen Diller Family Comprehensive Cancer CenterSan Francisco, CA NCI Comprehensive Active Research Program | 59.7 |
| 5 | Duke Cancer InstituteDurham, NC NCI Comprehensive Active Research Program | 59.7 |
| 6 | NCI Comprehensive Active Research Program | 59.7 |
| 7 | Masonic Cancer CenterMinneapolis, MN NCI Comprehensive Active Research Program | 59.7 |
| 8 | Roswell Park Comprehensive Cancer CenterBuffalo, NY NCI Comprehensive Active Research Program | 59.7 |
| 9 | University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive Active Research Program | 59.7 |
| 10 | Holden Comprehensive Cancer CenterIowa City, IA NCI Comprehensive Active Research Program | 59.7 |
| 11 | University of Illinois Cancer CenterChicago, IL Active Research Program | 59.7 |
| 12 | Boston University Cancer CenterBoston, MA Active Research Program | 59.7 |
| 13 | Cancer Center at IllinoisUrbana, IL Active Research Program | 59.7 |
| 14 | Upstate Cancer CenterSyracuse, NY Active Research Program | 59.7 |
| 15 | NCI Comprehensive Active Research Program | 56.6 |
| 16 | Mayo Clinic Comprehensive Cancer CenterRochester, MN NCI Comprehensive Active Research Program | 54.1 |
| 17 | UNC Lineberger Comprehensive Cancer CenterChapel Hill, NC NCI Comprehensive Active Research Program | 52.9 |
| 18 | Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive | 37.2 |
| 19 | Fred Hutch Cancer CenterSeattle, WA NCI Comprehensive | 37.2 |
| 20 | UPMC Hillman Cancer CenterPittsburgh, PA NCI Comprehensive | 37.2 |
| 21 | NCI Comprehensive | 37.2 |
| 22 | Winship Cancer InstituteAtlanta, GA NCI Comprehensive | 37.2 |
| 23 | City of Hope Comprehensive Cancer CenterDuarte, CA NCI Comprehensive | 37.2 |
| 24 | USC Norris Comprehensive Cancer CenterLos Angeles, CA NCI Comprehensive | 37.2 |
| 25 | University of Colorado Cancer CenterAurora, CO NCI Comprehensive | 37.2 |
| 26 | Moffitt Cancer CenterTampa, FL NCI Comprehensive | 37.2 |
| 27 | The University of Arizona Cancer CenterTucson, AZ NCI Comprehensive | 37.2 |
| 28 | Cleveland Clinic Cancer CenterCleveland, OH | 37.2 |
| 29 | 37.2 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →